JPRN-UMIN000027668
Completed
Phase 3
Evaluation of the new 22-gauge EUS guided Biopsy Needle (Acqiure) Comparing to another new 20-gauge FNA needle with forward-cutting bevel (ProCore) in Patients With Autoimmune Pancreatitis : A Prospective Randomized, Controlled Multicenter Study - Comparing the diagnostic yield of EUS-FNA using ProCore and Acquire in patients with AIP (COMPAS study)
Bilio-Pancreatic Stenting study group0 sites110 target enrollmentAugust 1, 2017
Conditionstype 1 autoimmune pancreatitis
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- type 1 autoimmune pancreatitis
- Sponsor
- Bilio-Pancreatic Stenting study group
- Enrollment
- 110
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Uncorrectable coagulopathy (INR \> 1\.5\). Or uncorrectable thrombocytopenia (platelet \< 50,000\) 2\) Uncooperative patients 3\) Inaccessible lesions to EUS 4\) Patients with ASA criteria 3, 4, or 5 5\) Refusal to consent form
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
sefulness of 22G ProCore fine needle biopsy with capillary samplingNeoplasmsKCT0000722Asan Medical Center150
Completed
Not Applicable
19Gauge Fine Needle Biopsy (FNB) Versus 22Gauge FNB for Endoscopic Ultrasound Guided Liver Biopsy (EUS-LB)Chronic Liver DiseaseNCT04806607Geisinger Clinic42
Completed
Not Applicable
22G FNA Needle vs. 22G ProCore NeedlePancreatic NeoplasmNCT01394159AdventHealth56
Completed
Not Applicable
22 Gauge Needle for EUS Guided Tissue Acquisition of Samples for Histologic ExaminationAbdominal NeoplasmsNCT04032951Catholic University of the Sacred Heart100
Unknown
Not Applicable
Comparing of a 22G EUS Procore Fine Needle Biopsy Device and a 20G EUS Procore Fine Needle Biopsy DevicePancreas NeoplasmsNCT03803930Huazhong University of Science and Technology1,224